Known as the “Pharmacy of the world”, India is a hub for pharma manufacturing and occupies a hefty 20 per cent share in the global generics volume supply by manufacturing 60,000 different generic brands across 60 therapeutic areas. The industry is poised for considerable growth in the near future and is expected to reach $130 billion by 2030 (currently valued at $50 billion) (1). With an aim to become more value-driven, India’s pharma industry is looking beyond generics, targeting…
Read More…
Source: https://www.expresspharma.in/manufacturing-the-right-talent/